TY - JOUR
T1 - ERO1-PDI Redox Signaling in Health and Disease
AU - Jha, Vishwanath
AU - Kumari, Tripti
AU - Manickam, Vijayprakash
AU - Assar, Zahra
AU - Olson, Kirk L.
AU - Min, Jeong Ki
AU - Cho, Jaehyung
N1 - Publisher Copyright:
© Copyright 2021, Mary Ann Liebert, Inc., publishers 2021.
PY - 2021/11/1
Y1 - 2021/11/1
N2 - Significance: Protein disulfide isomerase (PDI) and endoplasmic reticulum oxidoreductase 1 (ERO1) are crucial for oxidative protein folding in the endoplasmic reticulum (ER). These enzymes are frequently overexpressed and secreted, and they contribute to the pathology of neurodegenerative, cardiovascular, and metabolic diseases. Recent Advances: Tissue-specific knockout mouse models and pharmacologic inhibitors have been developed to advance our understanding of the cell-specific functions of PDI and ERO1. In addition to their roles in protecting cells from the unfolded protein response and oxidative stress, recent studies have revealed that PDI and ERO1 also function outside of the cells. Critical Issues: Despite the well-known contributions of PDI and ERO1 to specific disease pathology, the detailed molecular and cellular mechanisms underlying these activities remain to be elucidated. Further, although PDI and ERO1 inhibitors have been identified, the results from previous studies require careful evaluation, as many of these agents are not selective and may have significant cytotoxicity. Future Directions: The functions of PDI and ERO1 in the ER have been extensively studied. Additional studies will be required to define their functions outside the ER.
AB - Significance: Protein disulfide isomerase (PDI) and endoplasmic reticulum oxidoreductase 1 (ERO1) are crucial for oxidative protein folding in the endoplasmic reticulum (ER). These enzymes are frequently overexpressed and secreted, and they contribute to the pathology of neurodegenerative, cardiovascular, and metabolic diseases. Recent Advances: Tissue-specific knockout mouse models and pharmacologic inhibitors have been developed to advance our understanding of the cell-specific functions of PDI and ERO1. In addition to their roles in protecting cells from the unfolded protein response and oxidative stress, recent studies have revealed that PDI and ERO1 also function outside of the cells. Critical Issues: Despite the well-known contributions of PDI and ERO1 to specific disease pathology, the detailed molecular and cellular mechanisms underlying these activities remain to be elucidated. Further, although PDI and ERO1 inhibitors have been identified, the results from previous studies require careful evaluation, as many of these agents are not selective and may have significant cytotoxicity. Future Directions: The functions of PDI and ERO1 in the ER have been extensively studied. Additional studies will be required to define their functions outside the ER.
KW - ERO1
KW - PDI
KW - disease
KW - inhibitors
KW - oxidative ER stress
KW - unfolded protein response
UR - http://www.scopus.com/inward/record.url?scp=85117069101&partnerID=8YFLogxK
U2 - 10.1089/ars.2021.0018
DO - 10.1089/ars.2021.0018
M3 - Review article
C2 - 34074138
AN - SCOPUS:85117069101
SN - 1523-0864
VL - 35
SP - 1093
EP - 1115
JO - Antioxidants and Redox Signaling
JF - Antioxidants and Redox Signaling
IS - 13
ER -